As of Aug 27
| +0.0055 / +1.44%|
The 5 analysts offering 12-month price forecasts for StemCells Inc have a median target of 1.75, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +351.03% increase from the last price of 0.39.
The current consensus among 5 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.